Cargando…

1863. Antibiotic Prescribing Before and After an FDA Boxed Warning on Fluoroquinolones in 2016

BACKGROUND: In July 2016, the FDA updated its boxed warning for fluoroquinolones (FQ) in light of ongoing safety concerns. Our objective was to examine trends in FQ and other antibiotic prescribing before and after the warning. METHODS: We analyzed electronic health records for inpatient, outpatient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willis, Zachary, Dusetzina, Stacie, Anderson, Deverick J, Pajewski, Nicholas, Kinlaw, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252433/ http://dx.doi.org/10.1093/ofid/ofy210.1519

Ejemplares similares

855. Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals
por: Yarrington, Michael, et al.
Publicado: (2018)

Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
por: Sankar, Ashwini, et al.
Publicado: (2021)

338. ChatGPT Conveys Incorrect Information about the FDA’s Antibiotic Boxed Warnings
por: Linfield, Rebecca, et al.
Publicado: (2023)

Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies
por: Hagan, John B., et al.
Publicado: (2021)

Public Perceptions of Breast Implant Complications and the FDA Boxed Warning on Implants
por: Hyland, Colby J., et al.
Publicado: (2022)

Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning
por: Cook, Benjamin L., et al.
Publicado: (2019)

Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan
por: Abbas, Muhammad, et al.
Publicado: (2023)

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates
por: Everson, Jordan, et al.
Publicado: (2020)

Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes
por: DiNicolantonio, James J., et al.
Publicado: (2013)

228. Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk
por: Li, Catherine, et al.
Publicado: (2020)

Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data
por: Georgi, Ulrike, et al.
Publicado: (2020)

The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?
por: Fornaro, Michele, et al.
Publicado: (2019)

Correction to: Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data
por: Georgi, Ulrike, et al.
Publicado: (2021)

Memoirs Read before the Anthropological Society of London, 1863-4
Publicado: (1865)

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
por: Kyle, Michael Anne, et al.
Publicado: (2022)

20. Fluoroquinolone and Overall Outpatient Antibiotic Prescribing Trends in Adults, 2011 to 2018
por: Gouin, Katryna A, et al.
Publicado: (2020)

FDA collaboration to improve safe use of fluoroquinolone antibiotics: an ex post facto matched control study of targeted short-form messaging and online education served to high prescribers
por: Whyte, John, et al.
Publicado: (2020)

Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses
por: Appaneal, Haley J., et al.
Publicado: (2023)

Establishing Antibiotic Stewardship Programs in Rural Hospitals to Decrease Fluoroquinolone Prescribing: The Vermont Experience
por: Smith, Lindsay M., et al.
Publicado: (2021)

Institutional response to FDA warning on aprotinin and impact on outcomes
por: Swaminathan, M, et al.
Publicado: (2009)

Scutari—March, 1863
por: Radcliffe, J. N.
Publicado: (1863)

The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2019)

Patterns of Fluoroquinolone Prescribing at a Tuberculosis Hospital
por: Kizilbash, Quratulain, et al.
Publicado: (2017)

The Effects of the FDA Warning on the Use of Droperidol by U.S. Emergency Physicians
por: Richards, John R., et al.
Publicado: (2003)

Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing
por: Yim, Seon-Hee, et al.
Publicado: (2014)

Susceptibility reporting and antibiotic prescribing for UTIs in the inpatient setting: A nudge toward improved stewardship
por: Ponder, Madison, et al.
Publicado: (2022)

Monografía de Xalapa 1863
por: Poyet, C. F.
Publicado: (1962)

Algunas campañas 1863-1876
por: Paz, Ireneo 1836-1924
Publicado: (1944)

Heinrich Sachs (1863–1928)
por: Forkel, Stephanie J.
Publicado: (2014)

Physician’s Visiting List, for 1863
Publicado: (1862)

1008. The Reduction of Fluoroquinolone Prescribing in Rural Vermont Hospitals
por: Smith, Lindsay, et al.
Publicado: (2019)

Fluoroquinolone antibiotics and adverse events
por: Baggio, Diva, et al.
Publicado: (2021)

Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
por: Spielmans, Glen I., et al.
Publicado: (2020)

Escritos jurídicos (1839-1863) : antología
por: Rodríguez de San Miguel, Juan N.
Publicado: (1992)

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
por: Chaloupka, Frank J, et al.
Publicado: (2015)

Impact of fluoroquinolone cascade reporting of urine samples on antibiotic prescribing rates in a network of urgent care clinics
por: Weichman, Brittani M., et al.
Publicado: (2022)

Causes Retarding Dental Progress: Read before the American Dental Convention, Aug. 8, 1863
por: Atkinson, Wm. H.
Publicado: (1863)

The Preservation of Natural Teeth: Read before the Central N. Y. Dental Association, Nov., 1863
por: Palmer, S. B.
Publicado: (1864)

Rapid streptococcal pharyngitis testing and antibiotic prescribing before and during the COVID-19 pandemic
por: Seibert, Allan, et al.
Publicado: (2022)

The application of Box-Behnken-Design in the optimization of HPLC separation of fluoroquinolones
por: Czyrski, Andrzej, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_45qmk4mf4kktqoqtn2ffotso2f